Home » Irradiators » KUBTEC XCELL TomoRad — Image-Guided Preclinical Irradiation

KUBTEC XCELL TomoRad — Image-Guided Preclinical Irradiation

Name: KUBTEC XCELL TomoRad — Image-Guided Preclinical Irradiation
Brand: KUBTEC

Overview

The XCELL TomoRad extends KUBTEC's irradiation line into image-guided radiotherapy. It takes a tomosynthesis 3D X-ray of the subject first and uses it to aim the dose, so radiation is delivered to the target rather than to the whole animal — the capability that separates a research irradiator from a cabinet that simply exposes a sample.

Use Cases

Preclinical radiotherapy studies: developing and testing tumour treatment plans with the dose directed at the target.
Normal-tissue effects: studying how healthy tissue responds to a defined, localised dose.
Cell and gene therapy research: conditioning and irradiation steps in therapy development.
Immunotherapy research: combining localised irradiation with immunological readouts.
In vitro and in vivo work: both cell-level and whole-animal irradiation studies on one system.

Unique Benefits

Image first, then treat: tomosynthesis imaging aligns the target before the dose is delivered, with 1 mm image slices supporting depth-dose calculation.
Targeted rather than whole-body: healthy tissue outside the target receives less dose.
Accessible: positioned between basic cabinet X-ray systems and large, complex clinical-style platforms, without demanding extensive dosimetry training.
Source-free: an X-ray alternative to caesium irradiators, avoiding the security and regulatory burden of a radioactive source.
Local support from Merkel: demonstration, installation, training and service in Israel.

Resources

KUBTEC XCELL TomoRad — Image-Guided Preclinical Irradiation

KUBTEC XCELL TomoRad — Image-Guided Preclinical Irradiation

To get more information or a quote for this product